Management of the greater trochanteric pain syndrome: a systematic review

Br Med Bull. 2012 Jun;102:115-31. doi: 10.1093/bmb/ldr038. Epub 2011 Sep 4.

Abstract

Introduction: Greater trochanteric pain syndrome (GTPS) is a debilitating condition characterized by lateral hip pain located at or around the greater trochanter.

Source of data: We performed a comprehensive search of Pubmed, Medline, Ovid, Google Scholar and Embase databases, from inception of the database to 20th of June 2011, using a variety of keywords. We identified 52 relevant abstracts of articles published in peer-reviewed journals. Fourteen studies reporting the outcomes of patients undergoing conservative and surgical management of GTPS were selected.

Areas of agreement: Significant pain relief and improved outcomes were observed after conservative and surgical management of GTPS. The modified Coleman methodology score averaged 44.7 (range from 14 to 82), evidencing an overall low-to-moderate quality of the studies. Repetitive low-energy radial shock wave therapy and home training approach provide beneficial effect over months, with almost 80% success rate at 15 months.

Areas of controversy: Poor available data extracted from small studies do not allow definitive conclusions to be drawn on the best treatment for GTPS.

Growing points: Further multi-centre prospective studies are necessary to confirm the general validity of the findings reported.

Areas timely for developing research: Future research and trials should focus on the application and effectiveness of the various conservative modalities for management of GTPS.

Conclusion: The effectiveness of the various treatment modalities needs to be tested in carefully conducted randomized controlled trials.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Arthralgia / diagnosis
  • Arthralgia / therapy*
  • Bursitis / diagnosis
  • Bursitis / therapy*
  • Glucocorticoids / therapeutic use
  • Hip Joint*
  • Humans
  • Orthopedic Procedures / methods
  • Syndrome

Substances

  • Glucocorticoids